Bruker Forges Three Research, Distribution Deals Covering MALDI Biotyper Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today announced deals with the Institute of Medical Microbiology at the University of Zurich, Francisco Soria Melguizo, and Viollier covering the MALDI Biotyper.

The collaboration with IMM focuses on the field of coryneform bacteria, actinomycetes, fastidious gram negative bacteria, and molds. The institute, which is the Swiss national reference center for mycobacteria, is using the MALDI Biotyper as its next-generation, rapid microbial identification system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.